Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 7, 1999

View Archived Issues

Novel echinocandin B tested in neutropenic rabbit model of disseminated candidiasis

In vivo antiangiogenic activity described for FMPA

Company Profile: AtheroGenics

Aurora Biosciences announces two new collaborations with Merck

COX-2 inhibitors: pros and cons debated in current literature

Teva signs letter of intent to acquire Novopharm

Very promising clinical trial results achieved with leukemia treatment

Hollis-Eden reports preliminary results from phase I/II HIV trial in South Africa

Factor Xa inhibitors described by Merck

New series of uroselective alpha1-adrenoceptor antagonists in development at Abbott

Cannabinoids with selectivity for CB2 receptor designed at U.S. university

GABA-A receptor agonists/inverse agonists disclosed by Dainippon

Novel hematinic agent SB-251353 has synergistic effects with G-CSF in preclinical models

Neuroprotective profile of new AMPA/kainate antagonist presented at Neuroscience meeting

Hughes Institute's COBRA compounds target a novel tubulin binding site

Pyridazinone cell adhesion inhibitors investigated as promising antiinflammatory agents

MR-2917: centrally acting muscle relaxant with reduced side effects

Optical resolution of TAN-67; analgesic activity resides in (-)-enantiomer

Gilead terminates U.S. development of adefovir dipivoxil for HIV

News flash: highlights from the AstraZeneca pipeline review

Neuroprotective use-dependent blocker of voltage-dependent Na+ channels, BIII-890-CL

Calpain inhibitor BDA-410 exerts neuroprotective effects in preclinical models

News from ASH: Hemolink performs extremely well in phase II trial in CABG patients

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...